MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
The EURO-PROBE dataset provides manually created segmentations of the prostate and intraprostatic urethra on axial T2-weighted MRI volumes, complementing the existing LUND-PROBE (LUND Prostate ...
A less expensive, more accessible, and comfortable alternative exists for those facing a prostate cancer biopsy, according to findings from a new clinical trial that Yale Urology contributed to.
Prostate cancer is one of the most commonly diagnosed cancers in American men, with estimates that 1 in 8 men will be diagnosed with the disease at some point in their life. Once cancer is suspected, ...
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between scans or start aggressive treatment. Those with certain types of medium-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results